ExCulture has an exclusive licence to a mixed culture fermentation bioprocess technology from TU Delft that they are developing as a novel method for producing heparin-like compounds. 

Their mission is to future-proof the supply chains of life-saving medications such as heparin through the implementation of a bio-based, animal-free approach.

ExCulture 400x300 1 v2

Contact details

Alexander Fleminglaan 1
2613 AX Delft
The Netherlands